RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis.

Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis.

Add to Collection
2018 Feb Systematic Review and Meta Analysis Fist_Author_Year_PM

Full Author : ['Bethel, M Angelyn', 'Patel, Rishi A', 'Merrill, Peter', 'Lokhnygina, Yuliya', 'Buse, John B', 'Mentz, Robert J', 'Pagidipati, Neha J', 'Chan, Juliana C', 'Gustavson, Stephanie M', 'Iqbal, Nayyar', 'Maggioni, Aldo P', 'Ohman, Peter', 'Poulter, Neil R', 'Ramachandran, Ambady', 'Zinman, Bernard', 'Hernandez, Adrian F', 'Holman, Rury R']
Journal Title : The lancet. Diabetes & endocrinology
Chapter : Section3
Journal Year : 2018
Cited by : Not Available

BACKGROUND: Glucagon-like peptide-1 (GLP-1) receptor agonists are effective glucose-lowering drugs. Findings from cardiovascular outcome trials showed cardiovascular safety of GLP-1 receptor agonists, but results for cardiovascular efficacy were varied. W.....

Keywords : ["glucagonlike receptor agonist", "type diabetes", "cardiovascular outcome", "patient", "metaanalysis"]